GATA3 and breast cancer: In both the METABRIC4 and TCGA breast cancer cohorts21, PR expression in ZnFn2 tumors was significantly lower than that in other GATA3-mutant tumors or in luminal breast tumors that express wild-type GATA3 (Fig. 7e; Supplementary Fig. 7g).